More than 200 employees participated in the CUIMC Team Relay Marathon, where teams of two to eight runners took turns running a combined 26.2 miles on The Armory’s 200-meter indoor track.
Jonathan Dworkin, PhD, professor of microbiology & immunology at the Vagelos College of Physicians and Surgeons, has been named a fellow of the American Association for the Advancement of Science.
More than 150 applicants accepted to Columbia’s medical school visited campus last week to get a look at what they can expect if they choose to attend VP&S.
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
In his book, “Living Cancer,” Columbia oncologist Michael Weiner tells the stories of his patients and reflects on his 360-degree view of cancer as a physician, patient, and parent.
A virtual town hall hosted by CUIMC and NewYork-Presbyterian Hospital brought together community health workers and local leaders to discuss questions and concerns regarding the COVID-19 vaccines.
New Columbia study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2.
A systematic screening program designed for athletes testing positive for COVID-19 has detected a low incidence of inflammatory heart disease, so far returning professional athletes safely to sport.
A 15-minute COVID-19 test that can be used at home to identify infectious people is under development in David Ho’s laboratory and has received support from the NYC Economic Development Corporation.
The first CUIMC Grand Rounds, launched by the four deans of Columbia University Irving Medical Center schools, was presented by David Ho, MD, on new variants of the coronavirus.